Skip to main content
Livermore
Livermore
ZHEN

Acrivon Therapeutics, Inc.

ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001781174

In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Acrivon Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−5 vs. Q2 2025
Shares held
17.5M
−279.4K (−1.6%) vs. Q2 2025
Total value
$31.7M
+$10.5M (+49.5%) vs. Q2 2025
New holders
6
11 more added
Sold out
11
19 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 48 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 18 institutionsQ1 2023: 39 institutionsQ2 2023: 40 institutionsQ3 2023: 43 institutionsQ4 2023: 42 institutionsQ1 2024: 48 institutionsQ2 2024: 55 institutionsQ3 2024: 55 institutionsQ4 2024: 63 institutionsQ1 2025: 63 institutionsQ2 2025: 53 institutionsQ3 2025: 48 institutionsQ4 2025: 48 institutionsQ1 2026: 44 institutionsQ2 2026: 46 institutions
Value heldQ3 2025: $31.7M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $170.4MQ1 2023: $191.1MQ2 2023: $196.0MQ3 2023: $144.3MQ4 2023: $74.5MQ1 2024: $109.0MQ2 2024: $136.1MQ3 2024: $160.8MQ4 2024: $140.0MQ1 2025: $45.7MQ2 2025: $21.2MQ3 2025: $31.7MQ4 2025: $44.9MQ1 2026: $22.6MQ2 2026: $38.1M
Institutions holding ACRV and their total value by quarter
QuarterHoldersValue
Q2 202646$38.1M
Q1 202644$22.6M
Q4 202548$44.9M
Q3 202548$31.7M
Q2 202553$21.2M
Q1 202563$45.7M
Q4 202463$140.0M
Q3 202455$160.8M
Q2 202455$136.1M
Q1 202448$109.0M
Q4 202342$74.5M
Q3 202343$144.3M
Q2 202340$196.0M
Q1 202339$191.1M
Q4 202218$170.4M
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding ACRV in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.8,340,508$15.1M0.19%00.0%Unchanged
Sands Capital Ventures, LLC2,122,605$3.84M0.84%00.0%Unchanged
Citadel Advisors LLC1,541,326$2.79M0.00%−354,193−18.7%Reduced
Wellington Management Group LLP888,130$1.61M0.00%00.0%Unchanged
UBS Group AG683,218$1.24M0.00%+682,763+150,057.8%Added
Vanguard Group Inc626,148$1.13M0.00%+32,901+5.5%Added
Renaissance Technologies LLC623,400$1.13M0.00%+114,105+22.4%Added
Acorn Capital Advisors, LLC405,237$733.5K0.37%00.0%Unchanged
BlackRock, Inc.330,957$599.0K0.00%−76,665−18.8%Reduced
Two Sigma Investments, LP319,205$577.8K0.00%+138,033+76.2%Added
Jane Street Group, LLC289,248$523.5K0.00%−22,581−7.2%Reduced
Geode Capital Management, LLC192,033$347.7K0.00%+27,671+16.8%Added
Millennium Management LLC185,234$335.3K0.00%−111,005−37.5%Reduced
Marshall Wace, LLP149,715$271.0K0.00%−31,472−17.4%Reduced
Two Sigma Advisers, LP136,500$247.1K0.00%+103,900+318.7%Added
Squarepoint Ops LLC104,324$188.8K0.00%−48,281−31.6%Reduced
Acadian Asset Management LLC92,004$165.0K0.00%+92,004New
State Street Corp67,145$121.5K0.00%00.0%Unchanged
Morgan Stanley57,160$103.5K0.00%−5,856−9.3%Reduced
Algert Global LLC44,648$80.8K0.00%+44,648New
Northern Trust Corp42,166$76.3K0.00%−4,610−9.9%Reduced
Bluefin Capital Management, LLC42,039$76.1K0.03%+42,039New
XTX Topco Ltd35,955$65.1K0.00%−70,164−66.1%Reduced
Bridgeway Capital Management, LLC22,900$41.4K0.00%00.0%Unchanged
Baker Bros. Advisors LP22,809$41.3K0.00%00.0%Unchanged
Barclays PLC19,965$36.1K0.00%−960−4.6%Reduced
Goldman Sachs Group Inc19,742$35.7K0.00%−120,313−85.9%Reduced
Dimensional Fund Advisors LP19,579$35.5K0.00%−2,625−11.8%Reduced
Bank of America Corp18,904$34.2K0.00%−1,713−8.3%Reduced
Citigroup Inc16,305$29.5K0.00%−16,077−49.6%Reduced
AAFCPAs Wealth Management, LLC10,678$19.3K0.01%+10,678New
Tower Research Capital LLC (TRC)8,736$15.8K0.00%−108−1.2%Reduced
FMR LLC8,622$15.6K0.00%−1,228−12.5%Reduced
China Universal Asset Management Co., Ltd.5,514$9.98K0.00%−784−12.4%Reduced
Federated Hermes, Inc.2,426$4.39K0.00%+108+4.7%Added
JPMorgan Chase & Co1,741$3.15K0.00%+323+22.8%Added
Mirae Asset Global Investments Co., Ltd.1,216$2.20K0.00%+5+0.4%Added
BNP Paribas Arbitrage, SA1,189$2.15K0.00%+197+19.9%Added
Royal Bank of Canada948$2.00K0.00%+917+2,958.1%Added
GF Fund Management Co. Ltd.650$1.18K0.00%−122−15.8%Reduced
Nisa Investment Advisors, LLC584$1.06K0.00%00.0%Unchanged
Redwood Park Advisors LLC500$9050.00%00.0%Unchanged
Russell Investments Group, Ltd.481$8710.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec400$7240.00%00.0%Unchanged
EverSource Wealth Advisors, LLC373$6750.00%+373New
SBI Securities Co., Ltd.74$1340.00%00.0%Unchanged
CWM, LLC127$00.00%−663−83.9%Reduced
Colony Group, LLC19,846––+19,846New
Jacobs Levy Equity Management, Inc0$00.00%−382,234−100.0%Sold out
HRT Financial LP0$00.00%−145,895−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−63,636−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−43,860−100.0%Sold out
AQR Capital Management LLC0$00.00%−22,252−100.0%Sold out
Quadrature Capital Ltd0$00.00%−22,175−100.0%Sold out
SG Americas Securities, LLC0$00.00%−15,265−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−12,692−100.0%Sold out
Ground Swell Capital, LLC0$00.00%−12,215−100.0%Sold out
True Wealth Design, LLC0$00.00%−176−100.0%Sold out
Wells Fargo & Company0$00.00%−141−100.0%Sold out